NewYork-Presbyterian announced today that it will establish a state-of-the-art, multi-specialty ambulatory care facility in White Plains, bringing an even broader range of its ambulatory, primary and preventive care services to the communities of Westchester County.

Cardiac faculty at Columbia and Weill Cornell Medicine launch a remote cardiac monitoring program and present an extensive review of the newest devices – both implantable and noninvasive.

A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according to the Weill Cornell Medicine and NewYork-Presbyterian physician-scientists who performed the transplant and managed her care.

A multi-institutional group in New York City has united to address health disparities in multiple chronic diseases through a new collaborative center.

Weill Cornell Medicine gastroenterology faculty identify the transfer of bacterial strains that correlate with treatment effectiveness of fecal microbiota transplantation for ulcerative colitis.

NewYork-Presbyterian/Columbia University Irving Medical Center is leading a global phase 1-3 clinical trial of an experimental drug – jacifusen – that may alter the progression of amyotrophic lateral sclerosis.

NewYork-Presbyterian/Weill Cornell Medical Center has received the Extracorporeal Life Support Organization (ELSO) Award for Excellence in Life Support, a recognition of its outstanding life support program.

Columbia researcher uncovers gene that solidifies the link between macular telangiectasia type 2 (MacTel) and serine deficiency and points the way to effective treatment.